Package 24450-647-30

{"route": ["INTRAVENOUS"], "spl_id": "21bdce90-ba9a-4304-876b-79a11840d532", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["6b7b71c9-f10c-4ace-8166-ea242d8e628d"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["BRIGHAM AND WOMEN`S HOSPITAL, INC., THE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (24450-647-30)", "package_ndc": "24450-647-30", "marketing_start_date": "20141030"}], "brand_name": "FLUDEOXYGLUCOSE F-18", "product_id": "24450-647_21bdce90-ba9a-4304-876b-79a11840d532", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "24450-647", "generic_name": "FLUDEOXYGLUCOSE F-18", "labeler_name": "BRIGHAM AND WOMEN`S HOSPITAL, INC., THE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FLUDEOXYGLUCOSE F-18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203816", "marketing_category": "ANDA", "marketing_start_date": "20141030", "listing_expiration_date": "20261231"}